"Vagus Nerve Stimulation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adjunctive treatment for PARTIAL EPILEPSY and refractory DEPRESSION that delivers electrical impulses to the brain via the VAGUS NERVE. A battery implanted under the skin supplies the energy.
| Descriptor ID |
D055536
|
| MeSH Number(s) |
E02.331.900
|
| Concept/Terms |
Vagus Nerve Stimulation- Vagus Nerve Stimulation
- Nerve Stimulation, Vagus
- Nerve Stimulations, Vagus
- Stimulation, Vagus Nerve
- Stimulations, Vagus Nerve
- Vagus Nerve Stimulations
- Vagal Nerve Stimulation
- Nerve Stimulation, Vagal
- Nerve Stimulations, Vagal
- Stimulation, Vagal Nerve
- Stimulations, Vagal Nerve
- Vagal Nerve Stimulations
|
Below are MeSH descriptors whose meaning is more general than "Vagus Nerve Stimulation".
Below are MeSH descriptors whose meaning is more specific than "Vagus Nerve Stimulation".
This graph shows the total number of publications written about "Vagus Nerve Stimulation" by people in this website by year, and whether "Vagus Nerve Stimulation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 3 | 3 | 6 |
| 2018 | 8 | 0 | 8 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vagus Nerve Stimulation" by people in Profiles.
-
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19. Front Immunol. 2020; 11:595342.
-
Treatment of Stage 3 COVID-19 With Transcutaneous Auricular Vagus Nerve Stimulation Drastically Reduces Interleukin-6 Blood Levels: A Report on Two Cases. Neuromodulation. 2021 01; 24(1):166-167.
-
COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway. Med Hypotheses. 2020 12; 145:110331.
-
Response to Letter to the Editor Regarding: "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience". Neuromodulation. 2020 10; 23(7):1044-1045.
-
Practice Guidelines for Canadian Neurophysiology Laboratories During the COVID-19 Pandemic. Can J Neurol Sci. 2021 01; 48(1):25-30.
-
Response to "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated with COVID-19: A Theoretical Hypothesis and Early Clinical Experience". Neuromodulation. 2020 10; 23(7):1042-1043.
-
Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome. Med Hypotheses. 2020 Oct; 143:110093.
-
A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial". Trials. 2020 Jun 26; 21(1):576.
-
Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19. J Cardiovasc Transl Res. 2020 12; 13(6):894-899.
-
The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience. Neuromodulation. 2020 Aug; 23(6):784-788.